Status:
UNKNOWN
Exposure Initializes Therapy - Treatment Of Homebound Patients Extended
Lead Sponsor:
Charite University, Berlin, Germany
Collaborating Sponsors:
Humboldt-Universität zu Berlin
Stiftung Deutsche Klassenlotterie Berlin
Conditions:
Agoraphobia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cognitive behavioral treatment of homebound patients with severe agoraphobia.
Detailed Description
Homebound patients with severe agoraphobia are treated with an exposure focussed cognitive behavioral therapy. The treatment begins at home. With a quick onset of guided exposure, patients get the pos...
Eligibility Criteria
Inclusion
- agoraphobia with/without Panic disorder
Exclusion
- psychotic disorders
- bipolar disorders
- acute substance dependency
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04460378
Start Date
January 1 2018
End Date
October 1 2020
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité - Universitätsmedizin Berlin
Berlin, Germany, 10117